PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists. [electronic resource]
Producer: 20190903Description: 1384-1389 p. digitalISSN:- 1532-0979
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- B7-H1 Antigen -- analysis
- Biomarkers, Tumor -- analysis
- Carcinoma, Non-Small-Cell Lung -- chemistry
- Chemotherapy, Adjuvant
- Clinical Decision-Making
- Female
- Humans
- Immunohistochemistry -- methods
- Lung Neoplasms -- chemistry
- Male
- Middle Aged
- Observer Variation
- Pathologists -- education
- Patient Selection
- Predictive Value of Tests
- Reagent Kits, Diagnostic
- Reproducibility of Results
- Tissue Array Analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.